National ADAP Monitoring Project, Annual Report, April 2002
This report, the sixth in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs) and documents how these programs are responding to the changing fiscal, clinical and epidemiological dynamics of HIV/AIDS. ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS in the 50 states, the District of Columbia, Puerto Rico, Guam and the Virgin Islands.
The report is commissioned by the Foundation and conducted by the National Alliance of State and Territorial AIDS Directors (NASTAD) and the AIDS Treatment Data Network (ATDN).
also of interest
- What Drives Spending and Utilization on Medicaid Drug Benefits in States?
- Medicaid in an Era of Health & Delivery System Reform: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2014 and 2015
- Medicare Part D: A First Look at Plan Offerings in 2015
- The Medicare Prescription Drug Benefit Fact Sheet